Study of Panobinostat Monotherapy in Women With HER2-negative Locally Recurrent or Metastatic Breast Cancer
NCT00777049
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
54
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Panobinostat
Sponsor
Translational Research in Oncology